Searched for
CONCERT PHARMACEUTICALS
India’s trade strategy: Moving beyond FTAsCurrently, India’s FTA utilisation rate hovers around 25% compared to 70-80% in developed economies.- An SNL 'All Drug Olympics?' Not quite. But these Enhanced Games are no jokeThe "Enhanced Games" in Las Vegas allows athletes to use performance enhancers, aiming to challenge mainstream sports' anti-doping efforts ...
- Biocon inks licensing, supply pact with Tabuk Pharmaceutical Manufacturing CoBiocon Ltd has signed a licensing and supply agreement with Tabuk Pharmaceutical Manufacturing Company to commercialise its GLP-1 products ...
- 4 reasons Sun Pharma is this week's stock pickSun Pharma’s 2022 annual report estimates that the global pharmaceutical market will grow by $400 billion between 2021 and 2026.
- 'Sun Pharma eyes deals to push specialty play, EM business'Sun Pharma, India's largest drugmaker, is looking at acquisitions to boost its specialty pipeline and strengthen emerging markets business....
- US FDA halts Sun Pharma's trials on dermatological drugThe FDA has also said that patients with alopecia areata - an autoimmune condition that results in patchy hair loss - on the 12 mg dose of ...
- Sun Pharma completes acquisition of Concert PharmaceuticalsThe drug major has successfully completed the acquisition of Concert Pharmaceuticals, Inc, a late-stage clinical biopharmaceutical company ...
- Hold Sun Pharmaceutical Industries, target price Rs 1001: ICICI SecuritiesSun Pharmaceutical Industries, incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 244576.21 Crore) operating ...
- Sun Pharma to buy concert for $576 mConcert has pioneered the use of deuterium (a hydrogen isotope) in medicinal chemistry and has an extensive patent portfolio, including its...
- Sun Pharma to acquire US-based Concert for $576 millionConcert's lead candidate, deuruxolitinib, is being evaluated as a treatment for autoimmune condition alopecia areata, which results in patc...
- Sun Pharma to acquire US-based Concert for $576 millionConcert's lead candidate, deuruxolitinib, is being evaluated as a treatment for autoimmune condition alopecia areata, which results in patc...
- First drug to treat hair loss disorder alopecia gets FDA approvalU.S. FDA has approved Eli Lilly's drug, Olumiant, which is considered the first to treat severe hair loss.
- Harry-Meghan ask to donate for Covid vaccine on Archie's birthdayArchie turned two on Thursday.
- Urgent action required to revive the pharma ancillary industry: IPAFor the revival of the ancillary industry, several short-term and long-term efforts are required to be made by all stakeholders, a report o...
- Urgent action required to revive the pharma ancillary industry: IPAFor the revival of the ancillary industry, several short-term and long-term efforts are required to be made by all stakeholders, a report o...
- Indian Pharma industry aspiring to grow to $120-130 billion by 2030: IPAThe report is based on a research collaboration with McKinsey & Co and inputs from the IPA members and industry leaders, IPA said in a stat...
- Manmohan Singh condemns terror attack in NairobiManmohan Singh today condemned the terror attack in Nairobi in which two Indians were among those killed.
- India-Russia set $20 billion trade target in 5 yearsThe two countries identified pharmaceuticals, energy, IT & communication, chemicals & fertilisers and banking & finance as thrust areas in ...
- IT, energy can push exports to $1 tn by 2020: FIEOSectors like IT and energy have the potential to raise the value of India's exports to $1 trillion, or 5 percent of the global trade, by 20...
- India to drag EU to WTO over the issue of patentsThe tussle between Indian generic drug industry and western innovative pharmaceutical firms is set to get stronger as India is considering ...
Load More
